DUBAÏ, Émirats arabes unis et RIYAD, Arabie Saoudite, 15 mai 2023 /PRNewswire/ — TVM Capital Healthcare, une société de capital-investissement spécialisée dans les soins de santé opérant dans les marchés émergents, a annoncé aujourd’hui l’ouverture d’un nouveau bureau dans la capitale du Royaume d’Arabie Saoudite. L’objectif de ce nouveau bureau est de conseiller le groupe … Read more
DxI 9000 Access Immunoassay Analyzer Boasts Industry’s Highest Throughput per Footprint: Up To 215 Tests/Hour/Square Meter Innovations Bolster Assay Performance and Laboratory Productivity with New Analyte Processing and Detection Technology, Precision Sensors, Smart Algorithms, Remote Real-Time System Monitoring, and is the Only Immunoassay Analyzer with No Daily Maintenancei NT-proBNP Assay Now Available with Age-Based Cutoffs … Read more
DUBAI, UAE and RIYADH, Saudi Arabia, May 15, 2023 /PRNewswire/ — TVM Capital Healthcare, a global specialist healthcare private equity firm operating in emerging markets, announced today the opening of a new office in the capital of the Kingdom of Saudi Arabia. The purpose of the new office is to advise the group and its portfolio … Read more
SHANGHAI, May 15, 2023 /PRNewswire/ — Rona Therapeutics, Inc (“Rona”) and Keymed Biosciences (“Keymed”, HKEX: 02162), today announced a collaboration to jointly discover and develop first-in-class siRNA therapeutics for Glomerulonephritis (also referred as severe kidney diseases). The collaboration will leverage both companies’ scientific and technological expertise and will build on Rona’s proprietary platform in RNAi … Read more
SHANGHAI, May 15, 2023 /PRNewswire/ — Rona Therapeutics, Inc (“Rona”) and Keymed Biosciences (“Keymed”, HKEX: 02162), today announced a collaboration to jointly discover and develop first-in-class siRNA therapeutics for Glomerulonephritis (also referred as severe kidney diseases). The collaboration will leverage both companies’ scientific and technological expertise and will build on Rona’s proprietary platform in RNAi … Read more
HANGZHOU, China, May 15, 2023 /PRNewswire/ — On May 12, MSCI, a leading provider of critical decision support tools and services for the global investment community, announced the results of the May 2023 Index Review for the MSCI Equity Indexes. Zylox-Tonbridge (2190.HK, “the Company”) is pleased to learn that the Company’s stock will be added … Read more
ROCKVILLE, Md. and SUZHOU, China, May 14, 2023 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, announced that the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) has granted … Read more
NEW YORK, May 14, 2023 /PRNewswire/ — The intrauterine contraceptive devices (IUD) market size is estimated to grow by USD 965.49 million during 2023-2027. However, the growth momentum will be progressing at a CAGR of 3.98% during the forecast period. The market is segmented by Type (Hormonal intrauterine device and Copper intrauterine device), End-user (Hospitals, Gynecology Clinics, and Others), … Read more
SAN DIEGO, May 14, 2023 /PRNewswire/ — Sorrento Therapeutics, Inc. (OTC: SRNEQ, “Sorrento”), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, intractable pain, and infectious disease, today announced that, in connection with its ongoing chapter 11 case, the U.S. Bankruptcy Court for the Southern District of Texas (the “Bankruptcy Court”) … Read more
WESTON, Fla., May 14, 2023 /PRNewswire/ — LolaVie, Jennifer Aniston’s plant-powered, science-perfected haircare brand, is proud to announce its partnership with the nation’s largest beauty retailer, Ulta Beauty, marking its first entry into brick and mortar. Beginning today, guests can shop the full range of LolaVie products in all 1,350+ Ulta Beauty locations and on … Read more